Overall rank by patents
#6,735
Across all tracked assignees
USPTO PatentsView assignee record - 49 granted patents across 46 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: D21C (PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR).
The verdict
Andritz holds 49 US patents across 46 technology areas, rank #6,735 of 50,000 tracked assignees.
Andritz OY has been granted 49 US utility patents between 2015 and 2025, placing Andritz OY at rank #6,735 across all assignees tracked by PlainPatent. This portfolio spans 46 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in D21C (PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR). As a Foreign Corporation, Andritz OY is one of the more focused assignees in the PatentsView dataset. By volume, Andritz sits between 4D Pharma Research Limited (49 patents, rank #6,731) and Bobrick Washroom Equipment, Inc. (49 patents, rank #6,739) - the closest US assignees by grant volume. The composite Innovation Score of 57.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 22 grants, compared with 27 in the 2015–2019 window, a -19% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Andritz OY's 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 46 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Andritz OY against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
4D Pharma Research Limited
49 patents
A.L.M.T. Corp.
49 patents
AGFA GRAPHICS NV
49 patents
AGJUNCTION LLC
49 patents
Aplix
49 patents
Astute Medical, Inc.
49 patents
BEYOND TWENTY LTD.
49 patents
BOBRICK WASHROOM EQUIPMENT, INC.
49 patents
ANDRITZ OY
49 patents
What this shows Andritz holds 49 patents at rank #6,735, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,735 in granted patent volume.
Other assignees with the most granted patents in Andritz's primary technology class.
Andritz's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
57 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 10.2% |
| 2016 | 4 | 8.2% |
| 2017 | 8 | 16.3% |
| 2018 | 4 | 8.2% |
| 2019 | 6 | 12.2% |
| 2020 | 1 | 2.0% |
| 2021 | 2 | 4.1% |
| 2022 | 4 | 8.2% |
| 2023 | 3 | 6.1% |
| 2024 | 6 | 12.2% |
| 2025 | 6 | 12.2% |
Top 15 of 46 technology areas
Overall rank by patents
#6,735
Across all tracked assignees
57.2 out of 100
How to use this portfolio
Andritz's 49 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.